All Articles

How iPSCs differ from cord blood, their medical uses and risks, and why banking cord blood now keeps options open for future iPSC therapies.

What are iPSCs and how they work: reprogrammed adult cells enabling personalized, embryo-free therapies, disease models, and future tissue repair.

iPSC therapies reprogram adult cells into personalized regenerative treatments, improve drug testing, and show why newborn stem cell banking matters.

How stem cell therapies are used in family medicine for tissue repair, wound healing, pain control, neurological and autoimmune care, and cord-blood banking.

Step-by-step guide to sibling cord blood transplants: HLA matching, collection, processing, transplant, engraftment, recovery, and banking benefits.

How patient-derived stem cells enable disease modeling, drug testing, gene editing and regenerative therapies—and why newborn stem cell banking matters.

How newborn stem cell banking, MSCs and exosome therapies repair tissues, reduce inflammation, and target age-related diseases like arthritis, Alzheimer's, and heart failure.

Overview of MSC and HSCT advances, gene editing and CAR technologies, clinical trial progress, risks, and cell banking for future autoimmune treatments.

How umbilical cord blood stem cells and exosomes support heart repair, summarize clinical findings, and explain cord blood banking benefits.